GPC3 and hepatocellular carcinoma: By using an aptamer to capture the target protein, it is possible to detect both alpha-fetoprotein (AFP) and glypican-3 (GPC3) in clinical specimens of hepatocellular carcinoma [101], also illustrated in Figure 4a.